Literature DB >> 16681553

Diabetes mellitus as a contributory factor in oral candidosis.

N S Soysa1, L P Samaranayake, A N B Ellepola.   

Abstract

It has been reported that poor glycaemic control predisposes to oral candidal infection in diabetic patients. For instance, the carriage of Candida species and the density of candidal growth in the oral cavity is frequently claimed to be increased in patients with diabetes mellitus. However, the validity of these observations remains controversial. Hence, we review and discuss here the clinical data in the literature on the relationship between diabetes and oral candidal carriage and infection, and possible mechanisms associated with its pathogenicity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16681553     DOI: 10.1111/j.1464-5491.2005.01701.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  35 in total

1.  IL-23 and IL-17A, but not IL-12 and IL-22, are required for optimal skin host defense against Candida albicans.

Authors:  Shinji Kagami; Heather L Rizzo; Stephen E Kurtz; Lloyd S Miller; Andrew Blauvelt
Journal:  J Immunol       Date:  2010-10-04       Impact factor: 5.422

2.  Geometric influence of the sagittal and vertical apical base relationship on the ANB angle.

Authors:  Reza Sadat-Khonsari; Henning Dathe; Michael Knösel; Wolfram Hahn; Dietmar Kubein-Meesenburg; Oskar Bauss
Journal:  J Orofac Orthop       Date:  2009-03-26       Impact factor: 1.938

3.  Local, systemic, demographic, and health-related factors influencing pathogenic yeast spectrum and antifungal drug administration frequency in oral candidiasis: a retrospective study.

Authors:  Moritz Hertel; Andrea Maria Schmidt-Westhausen; Frank-Peter Strietzel
Journal:  Clin Oral Investig       Date:  2015-10-19       Impact factor: 3.573

4.  Novel Nystatin A₁ derivatives exhibiting low host cell toxicity and antifungal activity in an in vitro model of oral candidosis.

Authors:  Joanna Boros-Majewska; Natalia Salewska; Edward Borowski; Sławomir Milewski; Sladjana Malic; Xiao-Qing Wei; Anthony J Hayes; Melanie J Wilson; David W Williams
Journal:  Med Microbiol Immunol       Date:  2014-06-13       Impact factor: 3.402

5.  Oral Manifestations and Complications of Diabetes Mellitus: A review.

Authors:  Awatif Y Al-Maskari; Masoud Y Al-Maskari; Salem Al-Sudairy
Journal:  Sultan Qaboos Univ Med J       Date:  2011-05-15

Review 6.  Malignant tumor-like gastric lesion due to Candida albicans in a diabetic patient treated with cyclosporin: a case report and review of the literature.

Authors:  Pasquale Mansueto; Giuseppe Pisciotta; Giovanni Tomasello; Daniela Cabibi; Aurelio Seidita; Alberto D'Alcamo; Angelo Maria Patti; Delia Sprini; Antonio Carroccio; Giovam Battista Rini; Gaetana Di Fede
Journal:  Clin Exp Med       Date:  2011-09-09       Impact factor: 3.984

7.  Candidal colonization, strain diversity, and antifungal susceptibility among adult diabetic patients.

Authors:  Safia A Al-Attas; Soliman O Amro
Journal:  Ann Saudi Med       Date:  2010 Mar-Apr       Impact factor: 1.526

8.  Genetic relatedness of commensal strains of Candida albicans carried in the oral cavity of patients' dental prosthesis users in Brazil.

Authors:  Regina Helena Pires-Gonçalves; Elaine Toscano Miranda; Lilian Cristiane Baeza; Marcelo Teruyuki Matsumoto; José Eduardo Zaia; Maria José Soares Mendes-Giannini
Journal:  Mycopathologia       Date:  2007-09-29       Impact factor: 2.574

9.  Facial Candidal Abscess in a Patient with Unknown Type 2 Diabetes Mellitus.

Authors:  Elif Peker; Fatma Zor; Mehmet Emin Toprak; Emre Bariş
Journal:  J Maxillofac Oral Surg       Date:  2014-10-07

10.  Inhaled corticosteroids and the occurrence of oral candidiasis: a prescription sequence symmetry analysis.

Authors:  Job F M van Boven; Lolkje T W de Jong-van den Berg; Stefan Vegter
Journal:  Drug Saf       Date:  2013-04       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.